Biosphere ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  9.1% 6.4% 5.3% 4.2% 7.2%  
Credit score (0-100)  28 37 41 48 32  
Credit rating  BB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  147 60 132 108 42  
Gross profit  135 53.9 127 92.4 25.8  
EBITDA  84.6 53.9 127 92.4 25.8  
EBIT  84.6 53.9 127 92.4 25.8  
Pre-tax profit (PTP)  85.2 55.4 126.3 90.8 22.8  
Net earnings  66.4 43.2 98.5 70.8 17.8  
Pre-tax profit without non-rec. items  85.2 55.4 126 90.8 22.8  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  116 166 265 221 209  
Interest-bearing liabilities  6.9 45.1 64.3 100 0.0  
Balance sheet total (assets)  156 244 378 382 214  

Net Debt  -29.6 -8.8 -123 -16.5 -75.0  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  147 60 132 108 42  
Net sales growth  0.0% -59.1% 120.0% -18.2% -61.1%  
Gross profit  135 53.9 127 92.4 25.8  
Gross profit growth  0.0% -60.0% 135.5% -27.2% -72.1%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  -50.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  156 244 378 382 214  
Balance sheet change%  0.0% 56.7% 54.7% 1.3% -44.1%  
Added value  134.6 53.9 127.0 92.4 25.8  
Added value %  91.8% 89.9% 96.2% 85.6% 61.3%  
Investments  0 0 0 0 0  

Net sales trend  0.0 -1.0 1.0 -1.0 -2.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  57.7% 89.9% 96.2% 85.6% 61.3%  
EBIT %  57.7% 89.9% 96.2% 85.6% 61.3%  
EBIT to gross profit (%)  62.9% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  45.3% 72.0% 74.7% 65.6% 42.4%  
Profit before depreciation and extraordinary items %  45.3% 72.0% 74.7% 65.6% 42.4%  
Pre tax profit less extraordinaries %  58.1% 92.3% 95.7% 84.1% 54.4%  
ROA %  54.7% 27.7% 40.6% 23.9% 7.7%  
ROI %  69.1% 31.9% 45.8% 27.9% 8.6%  
ROE %  57.1% 30.6% 45.8% 29.2% 8.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  74.7% 68.0% 70.1% 57.8% 97.6%  
Relative indebtedness %  26.8% 109.8% 85.6% 149.5% 12.1%  
Relative net indebtedness %  2.0% 20.0% -56.0% 41.3% -166.5%  
Net int. bear. debt to EBITDA, %  -35.0% -16.4% -96.7% -17.9% -291.0%  
Gearing %  5.9% 27.1% 24.3% 45.4% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  3.6 3.4 2.7 2.4 42.3  
Current Ratio  3.6 3.4 2.7 2.4 42.3  
Cash and cash equivalent  36.5 53.9 187.0 116.8 75.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  37.3 91.3 83.0 81.1 208.6  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  97.2% 376.6% 232.4% 354.1% 509.2%  
Net working capital  103.2 160.1 193.7 150.2 138.0  
Net working capital %  70.3% 266.8% 146.8% 139.0% 328.5%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0